BCMIO
TEVA icon

Beacon Capital Management Inc (Ohio)’s Teva Pharmaceuticals TEVA Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2
Closed – – 198
2017
Q1 		$0 Buy
+2
New +$68 ﹤0.01% 200

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s TEVA Position: Q2 2017 in Review

Beacon Capital Management Inc (Ohio) sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 2 shares.

Beacon Capital Management Inc (Ohio) first reported a position in TEVA in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 649 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Beacon Capital Management Inc (Ohio) reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 2 Teva Pharmaceuticals shares in Q2 2017.
  • Beacon Capital Management Inc (Ohio) first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 1 quarter.
  • Beacon Capital Management Inc (Ohio)'s Teva Pharmaceuticals position peaked at $0 in Q1 2017.
  • 649 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2017, filed 11 Jul 2017.